;

:

–

Cholesterol: the good, the bad, and the stopped trials. Lancet.

;

:

US Food and Drug Administration. Pfizer stops all torcetrapib clinical trials in interest of patient safety. December

,

Available at: http://www.fda.gov/bbs/topics/NEWS/

/NEW

html. Last accessed June

,

Zhong S, Sharp DS, Grove JS, et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest.

;

:

–

Inazu A, Koizumi J, Mabuchi H. CETP deficiency. Nippon Rinsho.

;

:

–

Curb JD, Abbott RD, Rodriguez BL, et al. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res.

;

:

–

Decision Editor: Luigi Ferrucci, MD, PhD